Werewolf Therapeutics HOWL
NASDAQ HOWL
$0.87 +0.44 (+102.57%)
At close: Aug 21, 2026 · 4:00 PM EDT

Werewolf Therapeutics (HOWL) Profit After Tax (2020 - 2026)

Werewolf Therapeutics (HOWL) posted quarterly Profit After Tax of $3.7 million for Q2 2026, up 120.41% year-over-year from $1.7 million in Q2 2025, and up 127.12% on a QoQ basis from -$13.5 million in Q1 2026.

Werewolf Therapeutics (HOWL) Profit After Tax (2020 - 2026) Analysis & Trends

Werewolf Therapeutics has reported Profit After Tax for 7 years, with the latest figure at $3.7 million in Q2 2026.

  • Profit After Tax for Q2 2026 came in at $3.7 million, up 120.41% year-over-year; the trailing twelve-month figure through Jun 2026 was -$34.6 million (up 52.68% YoY), and the FY2025 annual result was -$60.8 million, up 13.75% from the prior year.
  • Profit After Tax rose to $3.7 million in Q2 2026, from -$13.5 million in the prior quarter.
  • Over five years, Profit After Tax peaked at $3.7 million in Q2 2026 and troughed at -$20.4 million in Q4 2024.
  • A 5-year average of -$12.9 million and a median of -$14.1 million in 2022 frame the typical range for Profit After Tax.
  • The widest annual swing landed in 2024, when Profit After Tax sank 238.35%; it then soared 120.41% in 2026.
  • A 5-year view of Profit After Tax shows it stood at -$11.9 million in 2022, then slipped by 0.61% to -$12.0 million in 2023, then tumbled by 69.96% to -$20.4 million in 2024, then jumped by 58.92% to -$8.4 million in 2025, then jumped by 143.79% to $3.7 million in 2026.
  • Per Business Quant data, the three most recent Profit After Tax figures were $3.7 million in Q2 2026, -$13.5 million in Q1 2026, and -$8.4 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.10 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 1.30 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 472.00 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn -782.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 237.01 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 164.49 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn -355.03 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn -16.62 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 81.49 Mn
10 Werewolf Therapeutics 43.94 Mn 43.94 Mn - 3.67 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 3.67 Mn
Mar 31, 2026 -13.53 Mn
Dec 31, 2025 -8.38 Mn
Sep 30, 2025 -16.37 Mn
Jun 30, 2025 -17.98 Mn
Mar 31, 2025 -18.09 Mn
Dec 31, 2024 -20.40 Mn
Sep 30, 2024 -16.67 Mn
Jun 30, 2024 -17.25 Mn
Mar 31, 2024 -16.19 Mn
Dec 31, 2023 -12.00 Mn
Sep 30, 2023 -8.29 Mn
Jun 30, 2023 -5.10 Mn
Mar 31, 2023 -11.98 Mn
Dec 31, 2022 -11.93 Mn
Sep 30, 2022 -11.94 Mn
Jun 30, 2022 -14.59 Mn
Mar 31, 2022 -15.34 Mn
Dec 31, 2021 -17.87 Mn
Sep 30, 2021 -13.76 Mn